Clinical Trials Browser

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type

NCT06624189 2026-02-27

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

Enrolling by invitation

1,300 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT07405099 2026-02-27

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

Enrolling by invitation

100 enrolled

GastrointestinalGenitourinary

Kidney Failure, Chronic, Pancreatic Neoplasms

NCT07439913 2026-02-27

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

Enrolling by invitation

120 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT05041309 2026-02-25

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Enrolling by invitation

1,000 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT07158450 2026-02-25

NOECHO

Enrolling by invitation

50 enrolled

Heart Failure, Cardiotoxicity

NCT07400835 2026-02-24

Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

Enrolling by invitation

600 enrolled

Gynecologic

Endometrial Neoplasms

NCT05369611 2026-02-19

COVID-19 Experiences in the SELF Cohort

Enrolling by invitation

1,668 enrolled

COVID-19, Leiomyoma

NCT06412029 2026-02-19

HRSN

Enrolling by invitation

144 enrolled

Tumor-Agnostic

Neoplasms

NCT04693754 2026-02-18

EUS-RFA

Enrolling by invitation

100 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07417774 2026-02-18

RESTORE LB

Enrolling by invitation

40 enrolled

CNS

Glioblastoma

NCT00001620 2026-02-17

Screening for Hematology Branch Protocols

Enrolling by invitation

10,000 enrolled

Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Disease, Hematologic Diseases, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT01382082 2026-02-17

CANTAB

Enrolling by invitation

1,432 enrolled

BreastLymphoid

Breast Neoplasms, Lymphoma

NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

Enrolling by invitation

5,000 enrolled

LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT04996316 2026-02-13

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

Enrolling by invitation

1,141 enrolled

Breast

Breast Neoplasms

NCT07410403 2026-02-13

AI

Enrolling by invitation

10 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT06730685 2026-02-12

PHILUCA

Enrolling by invitation

160 enrolled

Thoracic

Cachexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma, Sarcopenia

NCT06701201 2026-02-10

A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product

Enrolling by invitation

60 enrolled

Tumor-Agnostic

Neoplasms

NCT07274579 2026-02-10

An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma

Enrolling by invitation

2,000 enrolled

Digestive Oncology

NCT06332131 2026-02-09

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

Enrolling by invitation

25 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Cardiotoxicity

NCT07395505 2026-02-09

PROS-PE

Enrolling by invitation

24 enrolled

Gastrointestinal

Rectal Neoplasms

NCT07383298 2026-02-03

Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase

Enrolling by invitation

100 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04254133 2026-01-30

GIFTS

Enrolling by invitation

1,360 enrolled

Genitourinary

Prostatic Neoplasms

NCT07372261 2026-01-30

PORTENT

Enrolling by invitation

1,000 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07373951 2026-01-29

DL-DriverBM

Enrolling by invitation

380 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT07376681 2026-01-29

Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health

Enrolling by invitation

2,000 enrolled

Breast

Breast Neoplasms

NCT07057284 2026-01-26

DENTOFACIAL-PBT Stage 2 - Feasibility Study

Enrolling by invitation

255 enrolled

Head & Neck

Congenital Abnormalities, Developmental Disabilities, Head and Neck Neoplasms, Neoplasms, Radiation Injuries

NCT07362706 2026-01-23

Gastric Cancer

Enrolling by invitation

240 enrolled

Gastrointestinal

Stomach Neoplasms, Sleep Apnea, Obstructive

NCT07358208 2026-01-22

PARTNER

Enrolling by invitation

3,000 enrolled

Gastrointestinal

Family History of Pancreas Cancer

NCT06472817 2026-01-21

Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men

Enrolling by invitation

80 enrolled

Genitourinary

Prostatic Neoplasms

NCT07346248 2026-01-16

POCAT

Enrolling by invitation

266 enrolled

Gastrointestinal

Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery

Clinical Trials

Development and Application of Patient-Derived Models of Cancer

Natural History Study of Early Life Exposures in Agriculture (ELEA)

Influencing Factors and Mechanisms of Capsular Contracture After Prosthesis Reconstruction in Patients With Breast Cancer

Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)

PERSIST

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

Optimal Surveillance Strategy After Positive FIT and Negative Colonoscopy

LTFS

Harvesting Cells for Experimental Cancer Treatments

ablation IN BE

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

Collection of Blood and Urine From Patients Undergoing Radiation Therapy

OPTIMA

Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

CPHMS

AFFEPAM

CONQUER

LEO

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

NOECHO

Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

COVID-19 Experiences in the SELF Cohort

HRSN

EUS-RFA

RESTORE LB

Screening for Hematology Branch Protocols

CANTAB

Pathogenesis of Hematologic Malignancies

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

AI

PHILUCA

A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product

An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

PROS-PE

Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase

GIFTS

PORTENT

DL-DriverBM

Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health

DENTOFACIAL-PBT Stage 2 - Feasibility Study

Gastric Cancer

PARTNER

Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men

POCAT